The development of amivantamab for the treatment of non-small cell lung cancer

by Danielle Brazel, Misako Nagasaka
Published 2023-10-01

The Development and Role of Capmatinib in the Treatment of MET-Dysregulated Non-Small Cell Lung Cancer—A Narrative Review

by Robert Hsu, David J. Benjamin, Misako Nagasaka
Published 2023-07-01

A Catalog of 5’ Fusion Partners in ROS1-Positive NSCLC Circa 2020

by Sai-Hong Ignatius Ou, MD PhD, Misako Nagasaka, MD
Published 2020-09-01

Will the clinical development of 4th-generation “double mutant active” ALK TKIs (TPX-0131 and NVL-655) change the future treatment paradigm of ALK+ NSCLC?

by Sai-Hong Ignatius Ou, Misako Nagasaka, Danielle Brazel, Yujie Hou, Viola W. Zhu
Published 2021-11-01

Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

by Keiko Tamaki, Tomoo Sato, Jun Tsugawa, Shinsuke Fujioka, Naoko Yagishita, Natsumi Araya, Junji Yamauchi, Ariella L. G. Coler-Reilly, Misako Nagasaka, Misako Nagasaka, Yasuhiro Hasegawa, Yoshihisa Yamano, Yoshihisa Yamano, Yoshio Tsuboi
Published 2019-09-01

Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity

by Tomoo Sato, Naoko Yagishita, Keiko Tamaki, Eisuke Inoue, Daisuke Hasegawa, Misako Nagasaka, Misako Nagasaka, Hiroko Suzuki, Natsumi Araya, Ariella Coler-Reilly, Yasuhiro Hasegawa, Yoshio Tsuboi, Ayako Takata, Yoshihisa Yamano, Yoshihisa Yamano
Published 2018-07-01

Catalog of 5’ Fusion Partners in ALK-positive NSCLC Circa 2020

by Sai-Hong Ignatius Ou, MD, PhD, Viola W. Zhu, MD, PhD, Misako Nagasaka, MD
Published 2020-03-01

Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer

by Misako Nagasaka, Mohammed Hafiz Uddin, Mohammed Najeeb Al-Hallak, Sarah Rahman, Suresh Balasubramanian, Ammar Sukari, Asfar S. Azmi
Published 2021-06-01

The Applicability of the Results in the Asian Population of ORIENT-11 to a Western Population According to the ICH-E5 Framework

by Stephen V. Liu, Misako Nagasaka, Victoria Stefaniak, Kristi Gruver, Yong Lin, David Ferry, Mark A. Socinski, Li Zhang
Published 2022-06-01

NTRK fusion positive colorectal cancer is a unique subset of CRC with high TMB and microsatellite instability

by Hui Wang, Zhi‐Wei Li, Qiuxiang Ou, Xue Wu, Misako Nagasaka, Yang Shao, Sai‐Hong Ignatius Ou, Yu Yang
Published 2022-07-01

Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated wit...

by Yukie Tanaka, Yukie Tanaka, Tomoo Sato, Tomoo Sato, Naoko Yagishita, Junji Yamauchi, Junji Yamauchi, Natsumi Araya, Satoko Aratani, Satoko Aratani, Katsunori Takahashi, Yasuo Kunitomo, Misako Nagasaka, Misako Nagasaka, Yoshinobu Kanda, Yoshinobu Kanda, Kaoru Uchimaru, Kaoru Uchimaru, Tomohiro Morio, Yoshihisa Yamano, Yoshihisa Yamano
Published 2022-08-01

In Response to Dr. Steven Sorscher

by Shannon S. Zhang, MD, Alexa B. Schrock, PhD, Misako Nagasaka, MD PhD, Sai-Hong Ignatius Ou, MD, PhD
Published 2023-01-01

STRN-ALK, A Novel In-Frame Fusion With Response to Alectinib

by Misako Nagasaka, MD, Nagaratna Sarvadevabatla, MD, Shawn Iwata, BSN, Yubin Ge, PhD, Ammar Sukari, MD, Christian Klosowski, MS, Ronald Yanagihara, MD
Published 2021-02-01

Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab

by Michael Lopez, Garo Hagopian, Linda Doan, Benjamin J. Lee, Nathan W. Rojek, Janellen Smith, Sai-Hong Ignatius Ou, Yesim Yilmaz Demirdag, Misako Nagasaka
Published 2023-10-01

Overview of Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Targeted Therapy and Supportive Care for Lung Cancer

by Kaleem Anwar, PharmD, Lee Nguyen, PharmD, Misako Nagasaka, MD, PhD, Sai-Hong Ignatius Ou, MD, PhD, Alexandre Chan, PharmD, MPH
Published 2023-02-01

Clinical and molecular characteristics of Chinese non‐small cell lung cancer patients with ERBB2 transmembrane domain mutations

by Yun Fan, Jinrong Qiu, Ruoying Yu, Ran Cao, Xiaoxi Chen, Qiuxiang Ou, Xue Wu, Yang W. Shao, Misako Nagasaka, Jiexia Zhang, Sai‐Hong Ignatius Ou
Published 2020-08-01

Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan

by Shuntaro Tsutsumi, Tomoo Sato, Naoko Yagishita, Junji Yamauchi, Natsumi Araya, Daisuke Hasegawa, Misako Nagasaka, Ariella L. G. Coler-Reilly, Eisuke Inoue, Ayako Takata, Yoshihisa Yamano
Published 2019-10-01

Health-Related Quality of Life Evaluation Using the Short Form-36 in Patients With Human T-Lymphotropic Virus Type 1-Associated Myelopathy

by Miyuna Kimura, Miyuna Kimura, Junji Yamauchi, Junji Yamauchi, Tomoo Sato, Tomoo Sato, Naoko Yagishita, Natsumi Araya, Satoko Aratani, Satoko Aratani, Kenichiro Tanabe, Erika Horibe, Toshiki Watanabe, Ariella Coler-Reilly, Misako Nagasaka, Misako Nagasaka, Yukari Akasu, Kei Kaburagi, Takayuki Kikuchi, Soichiro Shibata, Hirofumi Matsumoto, Akihito Koseki, Akihito Koseki, Soichiro Inoue, Ayako Takata, Yoshihisa Yamano, Yoshihisa Yamano
Published 2022-04-01

A Novel Sequentially Evolved EML4-ALK Variant 3 G1202R/S1206Y Double Mutation In Cis Confers Resistance to Lorlatinib: A Brief Report and Literature Review

by Viola W. Zhu, MD, PhD, Misako Nagasaka, MD, Russell Madison, BA, Alexa B. Schrock, PhD, Jean Cui, PhD, Sai-Hong Ignatius Ou, MD, PhD
Published 2021-01-01

Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance

by Husain Yar Khan, James Ge, Misako Nagasaka, Amro Aboukameel, Gabriel Mpilla, Irfana Muqbil, Mark Szlaczky, Mahmoud Chaker, Erkan Baloglu, Yosef Landesman, Ramzi M. Mohammad, Asfar S. Azmi, Ammar Sukari
Published 2019-12-01